Pediatric Radiology

, Volume 38, Issue 8, pp 848–856 | Cite as

Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients

Original Article

Abstract

Background

Biotinidase deficiency is a metabolic disorder characterized by inability to recycle biotin with resultant delayed myelination. Clinical findings include seizures, ataxia, alopecia and dermatitis with atypical findings of myoclonic jerks, neuropathy and spastic paraparesis. Neuroradiological findings include cerebral atrophy, encephalopathy and widened extracerebral CSF spaces. Many of the clinical and neuroradiological features are reversible except sensorineural hearing loss and optic atrophy.

Objective

To understand and describe the neuroimaging and spectroscopic findings of biotinidase deficiency.

Materials and methods

We evaluated the spectrum of neuroimaging and spectroscopic findings in four patients with biotinidase deficiency with follow-up studies in three patients.

Results

The imaging findings were encephalopathy, low cerebral volume, ventriculomegaly and widened extracerebral CSF spaces. Uncommon findings were caudate involvement, parieto-occipital cortical abnormalities and one patient with restricted diffusion. Two patients had subdural effusions, which is uncommon in biotinidase deficiency. 1H-MR spectroscopy revealed elevated lactate, reversal of the choline/creatine ratio and decreased NAA peaks. Follow-up studies revealed complete reversal of imaging findings in two patients.

Conclusion

Biotinidase deficiency is a reversible metabolic encephalopathy. This study highlights the importance of early and prompt cliniconeuroradiological diagnosis of biotinidase deficiency as it has an extremely good clinical outcome if treatment is initiated from early infancy.

Keywords

Biotinidase deficiency Encephalopathy MR spectroscopy Children 

References

  1. 1.
    Wolf B (1991) Worldwide survey of neonatal screening of biotinidase deficiency. J Inherit Metab Dis 14:923–937PubMedCrossRefGoogle Scholar
  2. 2.
    Wolf B (2001) Disorders of biotin metabolism. In: Scriver CR, Beaudet AL, Valle D et al (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3935–3962Google Scholar
  3. 3.
    Mardach R, Zempleni J, Wolf B et al (2002) Biotin deficiency due to a defect in biotin transport. J Clin Invest 109:1617–1623PubMedGoogle Scholar
  4. 4.
    Wolf B, Spencer R, Gleason T (2002) Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency. J Pediatr 140:242–246PubMedCrossRefGoogle Scholar
  5. 5.
    Dionisi-Vici C, Bachmann C, Graziani MC et al (1988) Laryngeal stridor as a leading symptom in a biotinidase-deficient patient. J Inherit Metab Dis 11:312–313PubMedCrossRefGoogle Scholar
  6. 6.
    Ataman M, Sozeri B, Ozalp I (1992) Biotinidase deficiency: a rare cause of laryngeal stridor. Int J Pediatr Otorhinolaryngol 23:281–284PubMedCrossRefGoogle Scholar
  7. 7.
    Baumgartner ER, Suormala TM, Wick H et al (1989) Biotinidase deficiency: a cause of subacute necrotising encephalomyelopathy (Leigh syndrome): report of a case with lethal outcome. Pediatr Res 26:260–266PubMedCrossRefGoogle Scholar
  8. 8.
    Tokatli A, Coskun T, Ozalp I et al (1992) The major presenting symptom in a biotinidase-deficient patient: laryngeal stridor. J Inherit Metab Dis 15:281–282PubMedCrossRefGoogle Scholar
  9. 9.
    Grunewald S, Champion MP, Leonard JV et al (2004) Biotinidase deficiency: a treatable leukoencephalopathy. Neuropediatrics 35:211–216PubMedCrossRefGoogle Scholar
  10. 10.
    Heller AJ, Stanley C, Shaia WT et al (2002) Localization of biotinidase in brain: implications for its role in hearing loss in biotinidase deficiency. Hear Res 173:62–68PubMedCrossRefGoogle Scholar
  11. 11.
    Wiznitzer M, Bangert B (2003) Biotinidase deficiency: Clinical and MRI findings consistent with myelopathy. Pediatr Neurol 29:56–58PubMedCrossRefGoogle Scholar
  12. 12.
    Honvar M, Janota I, Neville BG et al (1992) Neuropathology of biotinidase deficiency. Acta Neuropathol 84:461–464Google Scholar
  13. 13.
    Sander JE, Malamud N, Cowan MJ et al (1980) Intermittent ataxia and immunodeficiency with multiple carboxylase deficiencies: a biotin-responsive disorder. Ann Neurol 8:544–547PubMedCrossRefGoogle Scholar
  14. 14.
    Wolf B, Pomponio RJ, Norrgard KJ et al (1998) Delayed-onset profound biotinidase deficiency. J Pediatr 132:362–365PubMedCrossRefGoogle Scholar
  15. 15.
    Schulz PE, Weiner SP, Belmont JW et al (1988) Basal ganglia calcifications in a case of biotinidase deficiency. Neurology 38:1326–1328PubMedGoogle Scholar
  16. 16.
    Schurmann M, Engelbrecht V, Lohmeier K et al (1997) Cerebral metabolic changes in biotinidase deficiency. J Inherit Metab Dis 20:755–760PubMedCrossRefGoogle Scholar
  17. 17.
    Hoffman TL, Simon EM, Ficicioglu C (2005) Biotinidase deficiency: the importance of adequate follow-up for an inconclusive newborn screening result. Eur J Pediatr 164:298–301PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Shrinivas Desai
    • 1
  • Karthik Ganesan
    • 1
    • 3
  • Anaita Hegde
    • 2
  1. 1.Department of CT and MRIJaslok Hospital and Research CentreMumbaiIndia
  2. 2.Department of PaediatricsJaslok Hospital and Research CentreMumbaiIndia
  3. 3.Department of RadiologyUniversity of California, San DiegoSan DiegoUSA

Personalised recommendations